Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-29 3:26 pm Purchase |
2023-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
BLACKROCK INC BLK |
4,684,975 6.600% |
1,212,796 (+34.93%) |
Filing History |
| 2024-01-25 07:52 am Purchase |
2023-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
STATE STREET CORP STT |
4,417,056 6.240% |
1,332,919 (+43.22%) |
Filing History |
| 2023-12-11 5:15 pm Purchase |
2023-11-30 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
Eventide Asset Management, LLC | 11,559,975 16.340% |
3,745,936 (+47.94%) |
Filing History |
| 2023-11-17 5:12 pm Purchase |
2023-11-07 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
Citadel Advisors LLC | 3,839,829 5.400% |
2,335,959 (+155.33%) |
Filing History |
| 2023-10-10 3:40 pm Purchase |
2023-09-30 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
Eventide Asset Management, LLC | 7,814,039 11.070% |
7,814,039 (New Position) |
Filing History |
| 2023-06-20 4:30 pm Purchase |
2023-06-20 | 13D | Zentalis Pharmaceuticals, Inc. ZNTL |
Matrix Capital Management Company, LP | 13,959,973 19.810% |
4,760,000 (+51.74%) |
Filing History |
| 2023-03-09 7:16 pm Sale |
2022-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
SUN ANTHONY Y | 360,542 0.600% |
-2,631,365 (-87.95%) |
Filing History |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
PRICE T ROWE ASSOCIATES INC | 2,176,700 3.800% |
-2,206,181 (-50.34%) |
Filing History |
| 2023-02-14 12:02 pm Purchase |
2022-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
Avidity Partners Management LP | 5,150,000 9.000% |
2,127,210 (+70.37%) |
Filing History |
| 2023-02-14 10:52 am Sale |
2022-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,231,427 3.900% |
-396,982 (-15.10%) |
Filing History |
| 2023-02-13 3:54 pm Purchase |
2023-02-14 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
Capital International Investors | 3,048,182 5.300% |
3,048,182 (New Position) |
Filing History |
| 2023-02-09 12:46 pm Purchase |
2023-02-09 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
FMR CORP | 7,909,176 13.858% |
1,113,345 (+16.38%) |
Filing History |
| 2023-02-09 11:37 am Purchase |
2022-12-30 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
The Vanguard Group | 4,160,149 7.290% |
973,163 (+30.54%) |
Filing History |
| 2023-02-07 1:20 pm Purchase |
2022-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
STATE STREET CORP STT |
3,084,137 5.400% |
3,084,137 (New Position) |
Filing History |
| 2023-02-06 2:59 pm Purchase |
2022-12-30 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
WELLINGTON MANAGEMENT CO LLP | 3,618,493 6.340% |
3,618,493 (New Position) |
Filing History |
| 2023-02-01 4:54 pm Purchase |
2022-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
BLACKROCK INC BLK |
3,472,179 6.100% |
629,234 (+22.13%) |
Filing History |
| 2022-06-03 10:52 am Purchase |
2022-05-18 | 13D | Zentalis Pharmaceuticals, Inc. ZNTL |
Matrix Capital Management Company, LP | 9,199,973 16.450% |
4,850,694 (+111.53%) |
Filing History |
| 2022-02-14 5:07 pm Sale |
2021-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
Redmile Group LLC | 0 0.000% |
-2,416,406 (Position Closed) |
Filing History |
| 2022-02-14 5:01 pm Sale |
2021-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
VIKING GLOBAL INVESTORS LP | 2,118,284 4.700% |
-893,000 (-29.66%) |
Filing History |
| 2022-02-14 2:34 pm Purchase |
2021-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
PRICE T ROWE ASSOCIATES INC | 4,382,881 9.600% |
4,382,881 (New Position) |
Filing History |